The consensus report released by the Ronald and Nancy Reagan Research Institute of the Alzheimer's Association et al. concluded that using the APOE-epsilon 4 allele of the APOE gene alone as a biomarker for AD should be avoided [14]. This evidence concerns the gene APOE and Alzheimer disease.